Structure Therapeutics (GPCR) Return on Equity [ROE] (2023 - 2026)
Structure Therapeutics (GPCR) reported Return on Equity [ROE] of -15.34% for Q2 2026, up 7.08 percentage points from -22.41% a year earlier but down 3.84 percentage points from the prior quarter.
Powered by 
Analysis
Structure Therapeutics (GPCR) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Structure Therapeutics posted Return on Equity [ROE] of -11.86%, up 6.74 percentage points from FY2024.
- By year, Return on Equity [ROE] came in at -18.60% in FY2024 (+34.46 pp) and -53.06% in FY2023.
- Five-year quarterly Return on Equity [ROE] spans a low of -92.76% in Q1 2023 and a high of -11.50% in Q1 2026.
- Year over year, Return on Equity [ROE] has now increased in each of the last three quarters, with an average year-over-year change of +4.50 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2024 (a gain of 70.63 percentage points); the low point was Q3 2025 (a drop of 15.16 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -11.50% (Q1 2026), -12.35% (Q4 2025) and -27.32% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.95 Bn | 1,100.53 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 635.80 Bn | 555.66 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 506.62 Bn | 479.73 Bn | 12.70 Bn | - |
| 4 | Merck | 358.64 Bn | 313.02 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.18 Bn | 256.17 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.70 Bn | 239.39 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.74 Bn | 193.14 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.25 Bn | 169.45 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.25 Bn | 117.90 Bn | 10.94 Bn | 4.97% |
| 10 | Structure Therapeutics | 4.64 Bn | 3.29 Bn | - | -15.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.34% |
| Mar 31, 2026 | -11.50% |
| Dec 31, 2025 | -12.35% |
| Sep 30, 2025 | -27.32% |
| Jun 30, 2025 | -22.41% |
| Mar 31, 2025 | -16.97% |
| Dec 31, 2024 | -13.91% |
| Sep 30, 2024 | -12.16% |
| Jun 30, 2024 | -14.87% |
| Mar 31, 2024 | -22.13% |
| Dec 31, 2023 | -27.75% |
| Sep 30, 2023 | -37.80% |
| Jun 30, 2023 | -29.08% |
| Mar 31, 2023 | -92.76% |
API Access
Structure Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GPCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GPCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GPCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();